122 related articles for article (PubMed ID: 36097407)
1. The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness.
Chang JS; Cheng HH; Huang SC; Lin HH; Chang SC; Lin CC
ANZ J Surg; 2023 Jan; 93(1-2):182-195. PubMed ID: 36097407
[TBL] [Abstract][Full Text] [Related]
2. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of tumour sidedness in patients with stage II colon cancer: a single-centre retrospective study.
Iguchi K; Mushiake H; Fukushima T; Rino Y; Masuda M
ANZ J Surg; 2021 Apr; 91(4):E196-E202. PubMed ID: 33559326
[TBL] [Abstract][Full Text] [Related]
4. Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.
Guo D; Li X; Xie A; Cao Q; Zhang J; Zhang F; Li W; Chen J
J Clin Lab Anal; 2020 Apr; 34(4):e23132. PubMed ID: 31755593
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
7. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
8. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
[TBL] [Abstract][Full Text] [Related]
9. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of right-sided and left-sided colon cancer after curative resection.
Yang CY; Yen MH; Kiu KT; Chen YT; Chang TC
Sci Rep; 2022 Jul; 12(1):11323. PubMed ID: 35790871
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.
Gholamalizadeh H; Zafari N; Velayati M; Fiuji H; Maftooh M; Ghorbani E; Hassanian SM; Khazaei M; Ferns GA; Nazari E; Avan A
Clin Exp Med; 2023 Dec; 23(8):4369-4383. PubMed ID: 37405571
[TBL] [Abstract][Full Text] [Related]
12. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
[TBL] [Abstract][Full Text] [Related]
13. Systemic Inflammatory Biomarkers as Surrogate Markers for Stage in Colon Cancer.
Uludag SS; Sanli AN; Zengin AK; Ozcelik MF
Am Surg; 2022 Jun; 88(6):1256-1262. PubMed ID: 33596111
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: Which side is better outcome?
Lim DR; Kuk JK; Kim T; Shin EJ
Medicine (Baltimore); 2017 Oct; 96(42):e8241. PubMed ID: 29049212
[TBL] [Abstract][Full Text] [Related]
15. Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness.
Shalkamy MSA; Bae JH; Lee CS; Han SR; Kim JH; Kye BH; Lee IK; Lee YS
J Minim Invasive Surg; 2022 Jun; 25(2):53-62. PubMed ID: 35821690
[TBL] [Abstract][Full Text] [Related]
16. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
18. Impact of Colon Cancer Location on the Prognostic Significance of Nutritional Indexes and Inflammatory Markers.
Hayama T; Ozawa T; Asako K; Kondo R; Ono K; Okada Y; Tsukamoto M; Fukushima Y; Shimada R; Nozawa K; Matsuda K; Fujii S; Fukagawa T; Hashiguchi Y
In Vivo; 2021; 35(2):1261-1269. PubMed ID: 33622929
[TBL] [Abstract][Full Text] [Related]
19. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
